Department of Obstetrics and Gynecology, Houston, Methodist Hospital, Houston, TX.
NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
J Clin Oncol. 2024 Aug 10;42(23):2741-2746. doi: 10.1200/JCO.23.02335. Epub 2024 May 29.
JCO The aim of this study was to compare overall survival between open and minimally invasive radical hysterectomy with participants followed for 4.5 years. The primary objective was to evaluate whether minimally invasive surgery was noninferior in disease-free survival (DFS) to abdominal radical hysterectomy. Secondary outcomes included overall survival. Sample size was based on DFS of 90% at 4.5 years and 7.2% noninferiority margin for minimally invasive surgery. A total of 631 patients were enrolled: 319 assigned to minimally invasive and 312 to open surgery. Of these, 289 (90.6%) patients underwent minimally invasive surgery and 274 (87.8%) patients open surgery. At 4.5 years, DFS was 85.0% in the minimally invasive group and 96% in the open group (difference of -11.1; 95% CI, -15.8 to -6.3; = .95 for noninferiority). Minimally invasive surgery was associated with lower rate of DFS compared with open surgery (hazard ratio [HR], 3.91 [95% CI, 2.02 to 7.58]; < .001). Rate of overall survival at 4.5 years was 90.6% versus 96.2% for the minimally invasive and open surgery groups, respectively (HR for death of any cause = 2.71 [95% CI, 1.32 to 5.59]; = .007). Given higher recurrence rate and worse overall survival with minimally invasive surgery, an open approach should be standard of care.
本研究的目的是比较参与者随访 4.5 年后的开放式和微创根治性子宫切除术的总生存率。主要目的是评估微创手术在无病生存率(DFS)方面是否不劣于腹式根治性子宫切除术。次要结局包括总生存率。样本量基于 4.5 年时 DFS 为 90%和微创手术 7.2%的非劣效性边界。共纳入 631 例患者:319 例分配至微创组,312 例分配至开放手术组。其中,289 例(90.6%)患者行微创手术,274 例(87.8%)患者行开放手术。4.5 年时,微创组的 DFS 为 85.0%,开放组为 96.0%(差值为-11.1;95%CI,-15.8 至-6.3;非劣效性检验 =.95)。与开放手术相比,微创手术的 DFS 率较低(风险比[HR],3.91[95%CI,2.02 至 7.58]; <.001)。4.5 年时,微创组和开放组的总生存率分别为 90.6%和 96.2%(任何原因导致死亡的 HR 为 2.71[95%CI,1.32 至 5.59]; =.007)。鉴于微创手术复发率较高且总体生存率较差,应采用开放手术作为标准治疗方法。